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Glucose u lmzaUon in Rat l l~ ia l  ~ n  
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Bac~~rouzx/- Decmase m Ca ~" ul:~ake of sarcol~asm¢ re~tum (SR) and 
cleemase m SR Ca ~'-ATPase (SERCA2) wo~n and mRNA fevels heve 
been ~~l:..ü~~c--d m pat~ents w~l  congest~e hearl fadure (CHF) d).m to vanous 
cafdmc dLsmdem. We Ixemously shewed that ml'ub~bon of cammne s ~  
by 3-{222-t~Jù~~hyl h~ruum)  ~ t e  (MET-88) pmtected Mft ven- 
tncular (LV) sys'tobc and d~astof¢ functmt~ ~r~ a~s wtth mTocar~al mfarcl~on 
(MI). In the cunent study we evaluated effects of i~'~hffmn of camdme s~nttte- 
SLS on protem levels et SERCA2 and se~eral enz~nes retated w~th gtuco~e 
ut]kzatmn. 
Meffmds: We induced MI m rats by f~atmg reh antenor cmscenchng com- 
na w arten/, and adr~~ed 100 moßg/day of ME1"-88 (MET-88 group) m 
l~acebo (MI group) fm 20 days, Shem group unOerwenl only cardmc ex- 
posme and rece~nd l~acebo. We measumd protem ~e ls  of SERCA2 and 
em'ymes re=ated wdh glucose u~~~zatmn *n ctuo~ LV myocardml h~na les  
by Weslem blo~t~J 
Resu~s. In crude LV myocam~al homogenate, SERCA2 p«ofem level was 
~-,duced by 32% [p - C.05) m MI group compared wsth Sham group In 
con~asL tt was m~nt3,n no..,m..~.= ,n MET-88 group. Among the enzymes 
retated wdh glucose uttl~zahon, ~~~~~jen syntase and hexokmase decrased 
by 41% and by 29% r~,e ly  in MI (p - 0.05). The reduc~on wem 
attenualed by the MET-88 treatment. SR fractmn showed qual~tabvely mr~tar 
results. 
Conctus~n: Inh~blbon of c/lr~tt~o ~mthests attenuated epressed protorn 
tevel et SERCA2. It moduMted these el en,.-ymes related wrth glucose ut~- 
hzabon, wh~ch may be tavorable for glucose utd~zat~on a d glycogen storage 
untier tschemlc condl1~on 
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-~  The Preva lence  o f  Viable in 288 Myocard ium 
Pat ients With Congest ive  Heart  Fa i lure 
M Allen Auerbach. S. Yagoubi, S. Gambhir. 1". Simantov. M. Phelps. 
H. Scheibe;t, J. Czemin UCLA Schoof of Medicine. Los Angele& Cahfom~a. 
USA 
Background: The deteclion of myocardial viability is clinically impo'~ant for 
man~:~L;g patients (pts) wilh congestive heart failum (CHF). E.-C..~nsive areas 
of blood flow-metabofism mismatch (MM) by PET prediof tt,o recove~ of 
dysfunctional myocardium tollowing revasculadzation (CABG; functionally 
significant MM), while smafl areas of MM are associ«ted w~th an increased 
nsk ler cafOta¢ Ooath (progtx~tP_~ùy mgmtcant MM) Yet, the pmvatenco of 
myocardlal wablhty tn CHF pta remams unknown 
Metflod~: To Oetermme p~teac8  O1 n~/oca~~tat vla~ttTy chn~t N+13 
ammonlaJF.18 (!~owgt~os 0 PET stt.¢tm~ obtamed in ;288 CHF paTents 
(mean age: 62 ~ 10 yeam; mean LVEF L~ ¢ ~~) wem v~~ ~zeO 
tel presenc¢, (11 MM and match (M), The myo¢a~:~um was ~ Into 19 
Pe~t~' ,  prommat, r~ an¢i ~~tat Ix~ of the nnteno~ septum, a~,  
antemlateral, mfero~te~l, infenor and i n ~  walls imd ~x.  The LV 
¢t~mbet sLre wa~ Om(~~_ as severey, modemley, ~ ef~arged ~r 
MM was consKlemd "kmct~%!lly" s ~ m  d -5 segmenl~ (appmx. 25% 
O1 LV,myoca~kum) anc! "wognost¢alty" ~f¢ant  it «5 ~ wem 
mvolveO~ 
Resu/~ Fun¢l¢mally e~pnd¢,am MM o(:¢uùed fn 26% 0! pt~ wlth eeverety, 
26% wllh moOerately, 30% w~ md¢~/~ and 23% ~ normal LV m~e 
Ptognost*¢a!~, s~~ùf~ant MM o¢c~ned in 26% pts ~ sevem~y. 26% 
moderately, 30% wllh ffl*k~ erda~ and 33% w~~ Normal LV 
Conctus~ms: Rmc1~~atly and ~ l y  s~gn~l~ant amoums ol v~ù~e 
myocardmm occ~e m 26% and 21~- O1 unselected CHF pts retemed tel 
tll~ asses5ment o1 myo~ald~l v=abddy end fun¢tloß~ i ~ 1  fofim~n O
CABG can be expeofed in about 25% O1CHF pts. These wtth ~malle~ amoums 
of wabd~f rn~ght beneht pmgnom~ally from underg~ng revasculanzatmn. 
10:45 
~ ~ula~t ton  of Vlable Myocafdlum Favou~bly 
Influencu Len~ ~ ~ et Paùen~, Wllm 
Sev~re but Not ~ Iseheml¢ Left VeHdcular 
OysfuncUo. 
P+ Ma~,mo. CNR ms~u~e ot C~ca; P t~ok~,  P~~- On ~~tt  ot me VtP 
stu~; ~ Group Nuclear Card~Ax~ and Magne~ Reson~nce 
tnm~,~ Eteopean Sooerv ot Cart~o~. eaty 
Background: In pa~mnts w~th vanous degmes of tschem~c ler1 venmcular 
o~on.  Mlte is know about the ddferm~al effecl of comna~t revascular- 
tzat]on 
MeU'm~s: To tms atm, 22B patients (mean age 60 ~: 7 yrs) wtm prevz. 
ous myocardiad tnfarclmn, documented comnanj arten/dmease and mam- 
~ned ~a l~~ ur~emem corcmary revascuianza~on e~her by anomOamy or
surg~ aEfd IoTtg |ere1 foHow-up ~tLl~~t]Ofl. Doflltllartce Of 1~ VlablJlb/WaS 
deflned as a ~ned Tha~um-201 ul~ake m mine Ihan 50% of dysw~~- 
gm segments at res1 evaMatod in an anaton~,cai 11-segment model. C! Ih,e~e 
pat~x~s, 174 had a preoperalP,/e a n g ~  e j~ fracllon m the rarlge 
45-26% (Group I) and 54 ~ an ejec'lù:)n ~ ~25% (Group 2) Two 
ma~ched group of patents (group 3, 156 patmnts and group 4, 62 pat]ents) 
w~n the same electmn ~ ranges and vmb~lily/d~lunct~on mtm wem 
treated me~cafly The 4 groups dtd not differ wffh respecl to known deren'nr- 
nams et postmfarctmn pfognosts: ag(}, elec'bon fractmn, number of diseas,ed 
vessels and number of o'y~syner~c segments at rest. 
Results: tntraopefatnte mortalrty was 5% and 3% tn group 1 and 2, m- 
spectnmh/(p ns: The 48-month sunnval rafes wem not slat~sttcally d~ffefent 
in groups 1 and 3 cflaractenzed by an mferme~ale reduct;on of elect~n 
~ .  On the cor¢~ry, ~ ~ sunnval rates u=ere 92% and 72% m 
group 2 and 4 charactenzed by severe d ~ .  ~es~.,~.~tvely (p ~: 0.01). 
Conctustons. In patients wdh advanced mchemlc left venlncular dysfunc- 
tfon and dommance of tmsue vml:~l~~/, coronary revasculanzatmn s~n l ly  
mnproves k~~g-tetm ou~come and may ~ ~.~~-~~~t a rettable allematù/9 It:) hearl 
transp~nfat~n In pal~nts wdh moderafe d~sfunclmn, ~ 1  lherapy and 
cotonary ~ lanzatm'n  are ass(~aled wlth stmllar annual sunnval rates 
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~ Improved Exercise Per fo rmance  and Quallty o f  L i fe 
in Patlenls With Symptomatic Hypertensive Left 
Ventricular Hypertrophy by VDD Pacing: 
A Double-Bl ind Randomized  Cmss-over  Trtal 
O A. Kass. C-H. Chen, M Talbot, M. Nakayama. RS. KmvaL J Lima, 
Johns H,.~okms Un~=rsity. Batst.ere MD. USA 
B,3ckground Leff ventncular hy1~rtrophy (LVH) wùh chromc hy1~rtens~on 
may lead to exerttonat mtoleranco and congostwo heart fatture. Wo IeS1E'd 
the efficacy of chromc VDD pacmg, a proposed Iroatmenl for obsfru~we 
HCM. on thls seo0ndary fo:m ol LVH. 
Methods: Patmnts w~th LVH (NYHA-ltL 4-m. 5-1, artenal pressure: 160/92) 
on chrontc p and'er Ca 2" .l~ocker and diuretic thempy, recetved VDD pacmg 
w~th short AV delay to maiofam cont]nuouS HV aptcal preexcitalion. All had 
concentnc LVH (19 ± 0,6 mm wafl thlckness), and cavity oblilerat~on at rest 
er w~th dobutamine er Valsalva provocation. Pacmg was on er oft for lhe first 
3 mos. then switched for the next 3 mos in a randomized double-blind design. 
Exercise was stu~ied by treadmill-ergometr% 
ResultS: Maximal O~ consumpt~on (14.1 -- 1.0 BASE vs 16.7 ± 1.2 
pace-ON, p = 0.04, m 02/min~.g), 02 consumpt:cn, a1 anaerobic threshold 
